Custom antibody development

We offer world-leading antibody development platforms based on a proprietary RabMAb® rabbit monoclonal platform, a phage display platform (AxioMx), and a next-generation sequencing platform (NGS-RabMAb®)

Learn how scientists combined the benefits of rabbit antibodies with those of a monoclonal and how this led to the breakthrough of our RabMAb technology; offering a consistent level of high quality antibodies.